三位专家直击临床研究设计(新闻发布会)MedSci专访OCC2013:

2013-05-23 MedSci MedSci原创

第七届东方心脏病学会议(The 7th Oriental Congress of Cardiology,OCC 2013)于2013年5月23日在上海世博中心召开。本次会议由上海市医学会心血管病专科委员会主办,上海市十八家医院共同承办。 大会于5月23日下午15:00召开新闻发布会,MedSci就年轻医生如何进行高质量临床研究发表了提问。    MedSci通讯员

第七届东方心脏病学会议(The 7th Oriental Congress of CardiologyOCC 2013)于2013523日在上海世博中心召开。本次会议由上海市医学会心血管病专科委员会主办,上海市十八家医院共同承办。


大会于523日下午15:00召开新闻发布会,MedSci就年轻医生如何进行高质量临床研究发表了提问。 

 

MedSci通讯员:葛院士以及各位专家大家好,这里是MedSci——医学教育与临床研究学术服务平台,在临床过程中发现问题,然后进行科研设计,做临床研究,最后再回归临床,已经是临床医生的必经之路,目前很多年轻临床医生都在做临床研究,其中大部分也都瞄准了SCI论文发表,我们想请问,对于如何进行高质量的临床研究设计,主席团及各位专家有没有什么建议呢? 

何奔:这是一个很好的问题,我想这正是转化医学所focus的内容。就像你说所的,转化医学就关注在临床上提问题,那么研究的话,要去回答临床问题,不一定是临床研究,也可以是基础研究。但是它都包含在从临床上发现问题,提出问题,和解决的这么一个过程。好的临床研究可能取决于很多方面,包括你的资源,病人的来源是不是容易获得,以及如何来设计。这一方面,不是说我们一个会,就能解决的。关于年轻医生怎么来做好临床研究,它可能牵涉到一个教育问题。比如我们在葛院士、沈卫峰院长的带领下举办的东方会,除了传播知识以外,也涉及到教育方面,这个问题的后半部分,应该由继续教育论坛坛主方唯一教授来回答。 

方唯一:我的观点跟他们不一样,年轻医生就应该好好搞临床,临床不行,当什么大夫?我觉得年轻医生在年轻的时候,在主治医师以前,练好临床基本功,比一切都重要,谢谢。

葛均波:我补充一下这个问题。我们每年东方会都关注这个,每年的会议之前,不光是东方会,别的会议也都在关注临床研究问题。关于如何设计临床研究,这应该会有很长的一段路要走,比如原来我们以为张大夫看A组,李大夫看B组,两组一比较,哪一组的病人好了,那么谁的水平就高。其实不是这么回事。原来我们做病人也是这样,上午吃阿司匹林,下午吃波立维,对比一下,就是随机试验了。其实clinic trial 是非常严肃的事情,所以我们有些医院收集了很大数量的样本量,做了很多的病人,但是放眼国外的一些医院,每年发表二十多篇NEW ENGL J MED  LancetJAMA Circulation等等高水平的文章,他们的病例数并不是很多,每天只做两三位病人,但是随访做的很好,严格按照标准。相比之下,我们就比较随意,这样的资料统计分析起来就比较困难。所以我觉得一个good clinical practice,除了设计一个好的热点以外,很重要的一点就是well organised。最开始的时候,美国的ACCAG好多大科学家在做演讲的时候提到,我们通过什么什么研究,调查资料,结果发现根本不是这么回事,所以专门随访。我们国家现在也正逐渐走上正轨,尤其是近五年来,我国诞生了很多CRO,帮我们来搜集资料做随访。原来我们有时候投出去的文章,外国的专家会说这个结果好的难以置信,言下之意就是不大相信了。比如并发症大概10%左右,我们只有1%,他们就会提出质疑,是水平很高呢,还是怎么回事呢?其实我们有时候是失访,怕麻烦,就写了没有发生。

我觉得,随着我们对循证医学的逐渐认识,一个好的临床研究,必须是一个well controlled的多中心前瞻性随机对照。

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=11128, encodeId=64bb111288e, content=赞成年轻医生主要精力在基本功,但不等于不培养和提高科研素养, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4UPxx2yicnBjSMn8E9rianrglfQ5k49nkMZAnVDkKWS6rNpxFQwrSiaDf9IOcndxPVN3kicib3nzbKS8OdPwtbegib5F8iaX7CCNIurg/0, createdBy=bd3f103254, createdName=yebin0307, createdTime=Thu Aug 14 23:29:00 CST 2014, time=2014-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1703153, encodeId=a7af1e031537c, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Sun Sep 01 22:42:00 CST 2013, time=2013-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2052587, encodeId=08c0205258e14, content=<a href='/topic/show?id=a78e3e8631a' target=_blank style='color:#2F92EE;'>#发布会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37863, encryptionId=a78e3e8631a, topicName=发布会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6105386, createdName=宋威, createdTime=Fri Sep 27 00:42:00 CST 2013, time=2013-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5989, encodeId=a4ac59894f, content=很好,收益匪浅。, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=850842663, createdName=shengyu501, createdTime=Sun Aug 04 11:41:00 CST 2013, time=2013-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1352945, encodeId=e13313529456c, content=<a href='/topic/show?id=1d931321816' target=_blank style='color:#2F92EE;'>#OCC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13218, encryptionId=1d931321816, topicName=OCC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat May 25 11:42:00 CST 2013, time=2013-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1585660, encodeId=8623158566041, content=<a href='/topic/show?id=921a229382d' target=_blank style='color:#2F92EE;'>#临床研究设计#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22938, encryptionId=921a229382d, topicName=临床研究设计)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e91e17265707, createdName=lishiwen, createdTime=Sat May 25 11:42:00 CST 2013, time=2013-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605960, encodeId=74f9160596030, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat May 25 11:42:00 CST 2013, time=2013-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5737, encodeId=139f5e3777, content=不错不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=dingping, createdTime=Fri May 24 17:45:00 CST 2013, time=2013-05-24, status=1, ipAttribution=)]
    2014-08-14 yebin0307

    赞成年轻医生主要精力在基本功,但不等于不培养和提高科研素养

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=11128, encodeId=64bb111288e, content=赞成年轻医生主要精力在基本功,但不等于不培养和提高科研素养, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4UPxx2yicnBjSMn8E9rianrglfQ5k49nkMZAnVDkKWS6rNpxFQwrSiaDf9IOcndxPVN3kicib3nzbKS8OdPwtbegib5F8iaX7CCNIurg/0, createdBy=bd3f103254, createdName=yebin0307, createdTime=Thu Aug 14 23:29:00 CST 2014, time=2014-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1703153, encodeId=a7af1e031537c, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Sun Sep 01 22:42:00 CST 2013, time=2013-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2052587, encodeId=08c0205258e14, content=<a href='/topic/show?id=a78e3e8631a' target=_blank style='color:#2F92EE;'>#发布会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37863, encryptionId=a78e3e8631a, topicName=发布会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6105386, createdName=宋威, createdTime=Fri Sep 27 00:42:00 CST 2013, time=2013-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5989, encodeId=a4ac59894f, content=很好,收益匪浅。, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=850842663, createdName=shengyu501, createdTime=Sun Aug 04 11:41:00 CST 2013, time=2013-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1352945, encodeId=e13313529456c, content=<a href='/topic/show?id=1d931321816' target=_blank style='color:#2F92EE;'>#OCC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13218, encryptionId=1d931321816, topicName=OCC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat May 25 11:42:00 CST 2013, time=2013-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1585660, encodeId=8623158566041, content=<a href='/topic/show?id=921a229382d' target=_blank style='color:#2F92EE;'>#临床研究设计#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22938, encryptionId=921a229382d, topicName=临床研究设计)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e91e17265707, createdName=lishiwen, createdTime=Sat May 25 11:42:00 CST 2013, time=2013-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605960, encodeId=74f9160596030, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat May 25 11:42:00 CST 2013, time=2013-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5737, encodeId=139f5e3777, content=不错不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=dingping, createdTime=Fri May 24 17:45:00 CST 2013, time=2013-05-24, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=11128, encodeId=64bb111288e, content=赞成年轻医生主要精力在基本功,但不等于不培养和提高科研素养, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4UPxx2yicnBjSMn8E9rianrglfQ5k49nkMZAnVDkKWS6rNpxFQwrSiaDf9IOcndxPVN3kicib3nzbKS8OdPwtbegib5F8iaX7CCNIurg/0, createdBy=bd3f103254, createdName=yebin0307, createdTime=Thu Aug 14 23:29:00 CST 2014, time=2014-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1703153, encodeId=a7af1e031537c, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Sun Sep 01 22:42:00 CST 2013, time=2013-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2052587, encodeId=08c0205258e14, content=<a href='/topic/show?id=a78e3e8631a' target=_blank style='color:#2F92EE;'>#发布会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37863, encryptionId=a78e3e8631a, topicName=发布会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6105386, createdName=宋威, createdTime=Fri Sep 27 00:42:00 CST 2013, time=2013-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5989, encodeId=a4ac59894f, content=很好,收益匪浅。, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=850842663, createdName=shengyu501, createdTime=Sun Aug 04 11:41:00 CST 2013, time=2013-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1352945, encodeId=e13313529456c, content=<a href='/topic/show?id=1d931321816' target=_blank style='color:#2F92EE;'>#OCC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13218, encryptionId=1d931321816, topicName=OCC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat May 25 11:42:00 CST 2013, time=2013-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1585660, encodeId=8623158566041, content=<a href='/topic/show?id=921a229382d' target=_blank style='color:#2F92EE;'>#临床研究设计#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22938, encryptionId=921a229382d, topicName=临床研究设计)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e91e17265707, createdName=lishiwen, createdTime=Sat May 25 11:42:00 CST 2013, time=2013-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605960, encodeId=74f9160596030, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat May 25 11:42:00 CST 2013, time=2013-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5737, encodeId=139f5e3777, content=不错不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=dingping, createdTime=Fri May 24 17:45:00 CST 2013, time=2013-05-24, status=1, ipAttribution=)]
    2013-09-27 宋威
  4. [GetPortalCommentsPageByObjectIdResponse(id=11128, encodeId=64bb111288e, content=赞成年轻医生主要精力在基本功,但不等于不培养和提高科研素养, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4UPxx2yicnBjSMn8E9rianrglfQ5k49nkMZAnVDkKWS6rNpxFQwrSiaDf9IOcndxPVN3kicib3nzbKS8OdPwtbegib5F8iaX7CCNIurg/0, createdBy=bd3f103254, createdName=yebin0307, createdTime=Thu Aug 14 23:29:00 CST 2014, time=2014-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1703153, encodeId=a7af1e031537c, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Sun Sep 01 22:42:00 CST 2013, time=2013-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2052587, encodeId=08c0205258e14, content=<a href='/topic/show?id=a78e3e8631a' target=_blank style='color:#2F92EE;'>#发布会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37863, encryptionId=a78e3e8631a, topicName=发布会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6105386, createdName=宋威, createdTime=Fri Sep 27 00:42:00 CST 2013, time=2013-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5989, encodeId=a4ac59894f, content=很好,收益匪浅。, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=850842663, createdName=shengyu501, createdTime=Sun Aug 04 11:41:00 CST 2013, time=2013-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1352945, encodeId=e13313529456c, content=<a href='/topic/show?id=1d931321816' target=_blank style='color:#2F92EE;'>#OCC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13218, encryptionId=1d931321816, topicName=OCC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat May 25 11:42:00 CST 2013, time=2013-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1585660, encodeId=8623158566041, content=<a href='/topic/show?id=921a229382d' target=_blank style='color:#2F92EE;'>#临床研究设计#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22938, encryptionId=921a229382d, topicName=临床研究设计)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e91e17265707, createdName=lishiwen, createdTime=Sat May 25 11:42:00 CST 2013, time=2013-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605960, encodeId=74f9160596030, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat May 25 11:42:00 CST 2013, time=2013-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5737, encodeId=139f5e3777, content=不错不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=dingping, createdTime=Fri May 24 17:45:00 CST 2013, time=2013-05-24, status=1, ipAttribution=)]
    2013-08-04 shengyu501

    很好,收益匪浅。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=11128, encodeId=64bb111288e, content=赞成年轻医生主要精力在基本功,但不等于不培养和提高科研素养, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4UPxx2yicnBjSMn8E9rianrglfQ5k49nkMZAnVDkKWS6rNpxFQwrSiaDf9IOcndxPVN3kicib3nzbKS8OdPwtbegib5F8iaX7CCNIurg/0, createdBy=bd3f103254, createdName=yebin0307, createdTime=Thu Aug 14 23:29:00 CST 2014, time=2014-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1703153, encodeId=a7af1e031537c, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Sun Sep 01 22:42:00 CST 2013, time=2013-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2052587, encodeId=08c0205258e14, content=<a href='/topic/show?id=a78e3e8631a' target=_blank style='color:#2F92EE;'>#发布会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37863, encryptionId=a78e3e8631a, topicName=发布会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6105386, createdName=宋威, createdTime=Fri Sep 27 00:42:00 CST 2013, time=2013-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5989, encodeId=a4ac59894f, content=很好,收益匪浅。, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=850842663, createdName=shengyu501, createdTime=Sun Aug 04 11:41:00 CST 2013, time=2013-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1352945, encodeId=e13313529456c, content=<a href='/topic/show?id=1d931321816' target=_blank style='color:#2F92EE;'>#OCC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13218, encryptionId=1d931321816, topicName=OCC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat May 25 11:42:00 CST 2013, time=2013-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1585660, encodeId=8623158566041, content=<a href='/topic/show?id=921a229382d' target=_blank style='color:#2F92EE;'>#临床研究设计#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22938, encryptionId=921a229382d, topicName=临床研究设计)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e91e17265707, createdName=lishiwen, createdTime=Sat May 25 11:42:00 CST 2013, time=2013-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605960, encodeId=74f9160596030, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat May 25 11:42:00 CST 2013, time=2013-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5737, encodeId=139f5e3777, content=不错不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=dingping, createdTime=Fri May 24 17:45:00 CST 2013, time=2013-05-24, status=1, ipAttribution=)]
    2013-05-25 zhaojie88
  6. [GetPortalCommentsPageByObjectIdResponse(id=11128, encodeId=64bb111288e, content=赞成年轻医生主要精力在基本功,但不等于不培养和提高科研素养, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4UPxx2yicnBjSMn8E9rianrglfQ5k49nkMZAnVDkKWS6rNpxFQwrSiaDf9IOcndxPVN3kicib3nzbKS8OdPwtbegib5F8iaX7CCNIurg/0, createdBy=bd3f103254, createdName=yebin0307, createdTime=Thu Aug 14 23:29:00 CST 2014, time=2014-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1703153, encodeId=a7af1e031537c, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Sun Sep 01 22:42:00 CST 2013, time=2013-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2052587, encodeId=08c0205258e14, content=<a href='/topic/show?id=a78e3e8631a' target=_blank style='color:#2F92EE;'>#发布会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37863, encryptionId=a78e3e8631a, topicName=发布会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6105386, createdName=宋威, createdTime=Fri Sep 27 00:42:00 CST 2013, time=2013-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5989, encodeId=a4ac59894f, content=很好,收益匪浅。, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=850842663, createdName=shengyu501, createdTime=Sun Aug 04 11:41:00 CST 2013, time=2013-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1352945, encodeId=e13313529456c, content=<a href='/topic/show?id=1d931321816' target=_blank style='color:#2F92EE;'>#OCC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13218, encryptionId=1d931321816, topicName=OCC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat May 25 11:42:00 CST 2013, time=2013-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1585660, encodeId=8623158566041, content=<a href='/topic/show?id=921a229382d' target=_blank style='color:#2F92EE;'>#临床研究设计#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22938, encryptionId=921a229382d, topicName=临床研究设计)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e91e17265707, createdName=lishiwen, createdTime=Sat May 25 11:42:00 CST 2013, time=2013-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605960, encodeId=74f9160596030, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat May 25 11:42:00 CST 2013, time=2013-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5737, encodeId=139f5e3777, content=不错不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=dingping, createdTime=Fri May 24 17:45:00 CST 2013, time=2013-05-24, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=11128, encodeId=64bb111288e, content=赞成年轻医生主要精力在基本功,但不等于不培养和提高科研素养, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4UPxx2yicnBjSMn8E9rianrglfQ5k49nkMZAnVDkKWS6rNpxFQwrSiaDf9IOcndxPVN3kicib3nzbKS8OdPwtbegib5F8iaX7CCNIurg/0, createdBy=bd3f103254, createdName=yebin0307, createdTime=Thu Aug 14 23:29:00 CST 2014, time=2014-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1703153, encodeId=a7af1e031537c, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Sun Sep 01 22:42:00 CST 2013, time=2013-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2052587, encodeId=08c0205258e14, content=<a href='/topic/show?id=a78e3e8631a' target=_blank style='color:#2F92EE;'>#发布会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37863, encryptionId=a78e3e8631a, topicName=发布会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6105386, createdName=宋威, createdTime=Fri Sep 27 00:42:00 CST 2013, time=2013-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5989, encodeId=a4ac59894f, content=很好,收益匪浅。, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=850842663, createdName=shengyu501, createdTime=Sun Aug 04 11:41:00 CST 2013, time=2013-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1352945, encodeId=e13313529456c, content=<a href='/topic/show?id=1d931321816' target=_blank style='color:#2F92EE;'>#OCC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13218, encryptionId=1d931321816, topicName=OCC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat May 25 11:42:00 CST 2013, time=2013-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1585660, encodeId=8623158566041, content=<a href='/topic/show?id=921a229382d' target=_blank style='color:#2F92EE;'>#临床研究设计#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22938, encryptionId=921a229382d, topicName=临床研究设计)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e91e17265707, createdName=lishiwen, createdTime=Sat May 25 11:42:00 CST 2013, time=2013-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605960, encodeId=74f9160596030, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat May 25 11:42:00 CST 2013, time=2013-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5737, encodeId=139f5e3777, content=不错不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=dingping, createdTime=Fri May 24 17:45:00 CST 2013, time=2013-05-24, status=1, ipAttribution=)]
  8. [GetPortalCommentsPageByObjectIdResponse(id=11128, encodeId=64bb111288e, content=赞成年轻医生主要精力在基本功,但不等于不培养和提高科研素养, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4UPxx2yicnBjSMn8E9rianrglfQ5k49nkMZAnVDkKWS6rNpxFQwrSiaDf9IOcndxPVN3kicib3nzbKS8OdPwtbegib5F8iaX7CCNIurg/0, createdBy=bd3f103254, createdName=yebin0307, createdTime=Thu Aug 14 23:29:00 CST 2014, time=2014-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1703153, encodeId=a7af1e031537c, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Sun Sep 01 22:42:00 CST 2013, time=2013-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2052587, encodeId=08c0205258e14, content=<a href='/topic/show?id=a78e3e8631a' target=_blank style='color:#2F92EE;'>#发布会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37863, encryptionId=a78e3e8631a, topicName=发布会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6105386, createdName=宋威, createdTime=Fri Sep 27 00:42:00 CST 2013, time=2013-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5989, encodeId=a4ac59894f, content=很好,收益匪浅。, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=850842663, createdName=shengyu501, createdTime=Sun Aug 04 11:41:00 CST 2013, time=2013-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1352945, encodeId=e13313529456c, content=<a href='/topic/show?id=1d931321816' target=_blank style='color:#2F92EE;'>#OCC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13218, encryptionId=1d931321816, topicName=OCC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat May 25 11:42:00 CST 2013, time=2013-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1585660, encodeId=8623158566041, content=<a href='/topic/show?id=921a229382d' target=_blank style='color:#2F92EE;'>#临床研究设计#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22938, encryptionId=921a229382d, topicName=临床研究设计)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e91e17265707, createdName=lishiwen, createdTime=Sat May 25 11:42:00 CST 2013, time=2013-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605960, encodeId=74f9160596030, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat May 25 11:42:00 CST 2013, time=2013-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5737, encodeId=139f5e3777, content=不错不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=dingping, createdTime=Fri May 24 17:45:00 CST 2013, time=2013-05-24, status=1, ipAttribution=)]
    2013-05-24 dingping

    不错不错

    0

相关资讯

沈卫峰:临床医生晋升考核标准应当多元化MedSci专访OCC2013:

第七届东方心脏病学会议(The 7th Oriental Congress of Cardiology,OCC 2013)于2013年5月23日在上海世博中心召开。本次会议由上海市医学会心血管病专科委员会主办,上海市十八家医院共同承办,本次大会上,MedSci有幸采访到本次大会执行主席沈卫峰院长。   MedSci通讯员:沈教授您好,非常感谢您抽出时间接受MedSci的专访。在刚刚